Loading...
Loading...
Browse all stories on DeepNewz
VisitWill major US insurance providers update policies for the new obesity framework by mid-2025?
Yes • 50%
No • 50%
Official announcements or policy updates from major US insurance providers
Global Commission Proposes New Obesity Diagnosis Framework, Introducing Clinical and Pre-Clinical Categories
Jan 15, 2025, 05:33 AM
A global commission, involving more than 50 experts and supported by 76 medical organizations, has proposed a new framework for diagnosing obesity, moving away from the traditional reliance on body mass index (BMI). The commission, published in The Lancet Diabetes & Endocrinology, suggests that obesity should be diagnosed using broader criteria, including measurements like waist circumference, to avoid misdiagnosis. The new approach categorizes obesity into 'clinical obesity,' defined as a chronic illness with excess body fat causing organ damage and life-altering complications, and 'pre-clinical obesity,' where individuals have excess body fat but no ongoing illness. This redefinition aims to provide a more accurate diagnosis and better allocate healthcare resources, potentially affecting the prescription of weight-loss drugs and insurance coverage for obesity treatment.
View original story
Anthem • 25%
Other • 25%
Aetna • 25%
UnitedHealth Group • 25%
Increase Transparency • 25%
Improve Customer Service • 25%
Lower Premiums • 25%
No Significant Change • 25%
0-25% • 25%
26-50% • 25%
More than 75% • 25%
76-100% • 25%
25% to 50% • 25%
51% to 75% • 25%
Less than 25% • 25%
51-75% • 25%
76-100% • 25%
51-75% • 25%
26-50% • 25%
0-25% • 25%
Yes • 50%
No • 50%
European Association for the Study of Obesity • 25%
Other • 25%
British Medical Association • 25%
American Medical Association • 25%
Other changes • 25%
Increased security measures • 25%
Leadership restructuring • 25%
No major changes • 25%
No • 50%
Yes • 50%
BMI • 25%
Waist circumference • 25%
Combination of factors • 25%
Body fat percentage • 25%
Other • 25%
Novo Nordisk • 25%
Pfizer • 25%
Johnson & Johnson • 25%